Arrowstreet Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-58,888
| Closed | -$2.49M | – | 1837 |
|
|
2024
Q1 | $2.49M | Buy |
58,888
+19,332
| +49% | +$818K | ﹤0.01% | 1082 |
|
|
2023
Q4 | $1.65M | Sell |
39,556
-31,314
| -44% | -$1.31M | ﹤0.01% | 999 |
|
|
2023
Q3 | $2.67M | Buy |
+70,870
| New | +$2.67M | ﹤0.01% | 784 |
|
|
2021
Q3 | – | Sell |
-4,328
| Closed | -$311K | – | 1927 |
|
|
2021
Q2 | $311K | Buy |
+4,328
| New | +$311K | ﹤0.01% | 1741 |
|
|
2020
Q4 | – | Sell |
-23,607
| Closed | -$1.3M | – | 2593 |
|
|
2020
Q3 | $1.3M | Sell |
23,607
-16,583
| -41% | -$910K | ﹤0.01% | 1740 |
|
|
2020
Q2 | $2.67M | Buy |
40,190
+36,190
| +905% | +$2.41M | ﹤0.01% | 1340 |
|
|
2020
Q1 | $245K | Sell |
4,000
-50,506
| -93% | -$3.09M | ﹤0.01% | 1684 |
|
|
2019
Q4 | $4.79M | Sell |
54,506
-83,393
| -60% | -$7.33M | 0.01% | 870 |
|
|
2019
Q3 | $10.4M | Sell |
137,899
-13,980
| -9% | -$1.05M | 0.02% | 482 |
|
|
2019
Q2 | $13M | Sell |
151,879
-15,063
| -9% | -$1.29M | 0.03% | 430 |
|
|
2019
Q1 | $18M | Sell |
166,942
-24,266
| -13% | -$2.62M | 0.04% | 394 |
|
|
2018
Q4 | $16.2M | Sell |
191,208
-15,339
| -7% | -$1.3M | 0.04% | 331 |
|
|
2018
Q3 | $20.3M | Sell |
206,547
-4,700
| -2% | -$462K | 0.05% | 290 |
|
|
2018
Q2 | $24.4M | Buy |
211,247
+185,156
| +710% | +$21.4M | 0.06% | 271 |
|
|
2018
Q1 | $2.58M | Sell |
26,091
-79,850
| -75% | -$7.88M | 0.01% | 703 |
|
|
2017
Q4 | $11.1M | Buy |
+105,941
| New | +$11.1M | 0.03% | 422 |
|
|
2016
Q2 | – | Sell |
-8,137
| Closed | -$1.17M | – | 1545 |
|
|
2016
Q1 | $1.17M | Sell |
8,137
-50,652
| -86% | -$7.26M | ﹤0.01% | 933 |
|
|
2015
Q4 | $9.08M | Buy |
58,789
+47,338
| +413% | +$7.31M | 0.04% | 376 |
|
|
2015
Q3 | $1.63M | Buy |
11,451
+221
| +2% | +$31.5K | 0.01% | 798 |
|
|
2015
Q2 | $1.61M | Buy |
+11,230
| New | +$1.61M | 0.01% | 690 |
|